HEXA rs121907953: What Your Genotype Means
The rs121907953 variant is a rare genetic mutation located in the HEXA gene. It is recognized as a pathogenic variant associated with carrier status for Tay-Sachs disease, an inherited condition affecting the nervous system.
What each genotype means
Typical HEXA genotype
This genotype represents the common, non-mutated sequence for this specific location in the HEXA gene. Individuals with this result do not carry this specific pathogenic mutation associated with Tay-Sachs disease.
This is the most common genotype found in the general population.
Tay-Sachs carrier status
This genotype indicates you are a carrier of a pathogenic mutation in the HEXA gene. Carriers typically do not show symptoms of Tay-Sachs disease, as the condition is autosomal recessive and requires two copies of a mutation to manifest.
This genotype is rare in the general population, though carrier frequencies vary significantly by ancestry.
Associated with Tay-Sachs disease
This genotype indicates the presence of two copies of the pathogenic mutation, which is associated with Tay-Sachs disease. Tay-Sachs is a serious, inherited lysosomal storage disorder, and this result should be discussed with a medical professional or genetic counselor for clinical context and interpretation.
This genotype is extremely rare in the general population.
Understanding the Variant and Its Location
The variant rs121907953 is a specific change in the DNA sequence of the HEXA gene, which is situated on chromosome 15. In the context of human genetics, a single nucleotide variant (SNP) like this represents a variation at a single position in the genome. This particular variant is cataloged in major databases such as dbSNP and ClinVar, where it is classified as pathogenic. Its location within the HEXA gene is significant because this gene provides the blueprint for the alpha subunit of the hexosaminidase A enzyme. When a variant occurs here, it can disrupt the normal production or function of this critical enzyme, which is responsible for breaking down fatty substances in the brain and spinal cord. Understanding where this variant sits helps researchers and clinicians identify its potential impact on cellular processes.
The Role of the HEXA Gene
The HEXA gene is essential for the proper function of the lysosome, a structure within cells that acts as a recycling center. Specifically, the gene encodes the alpha subunit of the enzyme beta-hexosaminidase A. This enzyme works in tandem with other proteins to break down a fatty substance called GM2 ganglioside. When the HEXA gene contains pathogenic variants, the resulting enzyme may be absent, reduced in quantity, or dysfunctional. Without enough active enzyme, GM2 ganglioside accumulates to toxic levels within nerve cells, leading to the progressive damage observed in Tay-Sachs disease. Because this condition is inherited in an autosomal recessive pattern, an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the clinical symptoms of the disease.
Research and Clinical Significance
Scientific research has firmly established that rs121907953 is a pathogenic mutation linked to Tay-Sachs disease. Evidence from clinical databases indicates that individuals who carry one copy of this variant are considered carriers. Carriers typically do not show symptoms of the disease because they possess a second, functional copy of the HEXA gene that produces enough enzyme for normal cellular function. However, if two carriers have a child, there is a statistical possibility of passing on the condition. The evidence strength for this variant's pathogenicity is considered moderate to high in clinical literature, as it has been documented in individuals diagnosed with HEXA-related disorders. It is important to note that genetic testing results should always be interpreted by a qualified healthcare professional or genetic counselor who can provide context based on an individual's full clinical and family history.
Population Frequency and Distribution
The rs121907953 variant is classified as rare in the general population. Population databases like gnomAD aggregate sequencing data from diverse groups to help researchers understand how common specific variants are across different ancestries. For rare pathogenic variants like those in the HEXA gene, frequency can vary significantly between populations due to historical and demographic factors. Because this variant is rare, it is not commonly found in the general public, though it may be more prevalent in specific ethnic groups where certain genetic conditions have historically been more common. Genetic screening programs often focus on these specific populations to provide accurate carrier testing. If you have received information about this variant from a genetic test, it is recommended to discuss the implications with a medical professional to understand what it means for your specific health profile.
Navigating Genetic Information
Accessing genetic information can be empowering, but it is essential to use it correctly. A report of being a carrier for a variant like rs121907953 does not mean you have or will develop Tay-Sachs disease. Instead, it provides information about your genetic makeup that may be relevant for family planning. You cannot use this information to diagnose yourself or others, and it should not be used to make medical decisions without consulting a doctor. If you are concerned about your carrier status or family history, a genetic counselor can help you interpret your results, explain the inheritance patterns, and discuss testing options for your partner or family members. Always rely on clinical-grade testing and professional medical advice rather than self-interpretation of raw genetic data, as clinical context is vital for accurate health management.
How common is this variant?
The rs121907953 variant is considered rare in the general population, with its frequency varying significantly across different ancestral groups.
Frequently asked questions
What does it mean to be a carrier for Tay-Sachs?
Being a carrier means you have one copy of a pathogenic HEXA variant but do not have the disease yourself. You have a functional copy of the gene that allows your body to produce enough enzyme to function normally.
Can I develop Tay-Sachs if I am a carrier?
No, Tay-Sachs is an autosomal recessive condition, meaning you must inherit two pathogenic variants—one from each parent—to develop the disease. Carriers are generally healthy and do not show symptoms.
Should I get tested if my partner is a carrier?
If you are concerned about your carrier status, it is recommended to speak with a genetic counselor. They can help you understand the risks and determine if testing is appropriate for you and your partner.
Is there a cure for Tay-Sachs disease?
Currently, there is no cure for Tay-Sachs disease. Treatment focuses on managing symptoms and providing supportive care to improve the quality of life for affected individuals.
Where can I find more information about my genetic results?
You should discuss your genetic test results with your primary care physician or a board-certified genetic counselor. They can provide personalized information based on your specific report and family history.
Sources & further reading
Educational information only, last refreshed 9/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121907953?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HEXA
Pathogenic splice junction mutation (c.1421+1G>C / IVS12+1G>C) in HEXA leading to Tay-Sachs disease.
Pathogenic HEXA splice donor site mutation (c.1073+1G>A) causing Tay-Sachs disease, common in carrier screening panels for Ashkenazi Jewish and French Canadian ancestry.
This variant is a pathogenic mutation in the HEXA gene associated with carrier status for Tay-Sachs disease.
A 4-bp insertion (c.1278dupTATC, p.Tyr427IlefsTer5) in HEXA that accounts for over 70% of Tay-Sachs disease alleles in Ashkenazi Jewish carrier screening panels.
A canonical splice-donor variant (c.1421+1G>C) in HEXA resulting in absent functional beta-hexosaminidase A, representing a classical Tay-Sachs carrier allele.
Splice junction mutation (c.1073+1G>A) leading to absent hexosaminidase A enzyme activity and classic infantile Tay-Sachs disease in recessive inheritance.
